Spire Healthcare Group PLC (LON:SPI) has received a consensus recommendation of “Hold” from the ten brokerages that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is GBX 132.38 ($1.73).
Several research analysts have recently issued reports on the stock. UBS Group restated a “neutral” rating and issued a GBX 120 ($1.57) target price on shares of Spire Healthcare Group in a report on Monday, September 16th. Peel Hunt upgraded shares of Spire Healthcare Group to an “add” rating and set a GBX 155 ($2.03) price target for the company in a research report on Monday, September 16th. Liberum Capital reiterated a “hold” rating on shares of Spire Healthcare Group in a research report on Monday, August 5th. Royal Bank of Canada reiterated an “outperform” rating and issued a GBX 149 ($1.95) price target on shares of Spire Healthcare Group in a research report on Monday, September 9th. Finally, Barclays reiterated an “underweight” rating and issued a GBX 115 ($1.50) price target on shares of Spire Healthcare Group in a research report on Friday, August 9th.
Shares of Spire Healthcare Group stock traded up GBX 7.10 ($0.09) during trading hours on Monday, hitting GBX 121.40 ($1.59). The company had a trading volume of 507,702 shares, compared to its average volume of 1,770,000. The company’s 50-day moving average is GBX 110.83 and its two-hundred day moving average is GBX 119.25. Spire Healthcare Group has a twelve month low of GBX 95.25 ($1.24) and a twelve month high of GBX 141.30 ($1.85). The company has a debt-to-equity ratio of 120.55, a current ratio of 1.15 and a quick ratio of 0.90. The company has a market cap of $486.91 million and a P/E ratio of 30.35.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.